Single-dose COVID-19 vaccine triggers antibody response in mice

(American Chemical Society) Across the world, health care workers and high-risk groups are beginning to receive COVID-19 vaccines, offering hope for a return to normalcy amidst the pandemic. However, the vaccines authorized for emergency use in the U.S. require two doses to be effective, which can create problems with logistics and compliance. Now, researchers reporting in ACS Central Science have developed a nanoparticle vaccine that elicits a virus-neutralizing antibody response in mice after only a single dose.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news